Cerebrospinal fluid pro-inflammatory cytokines differentiate parkinsonian syndromes

Area of Science:

• Neuroscience
• Immunology
• Neurology

Background:

• Neuroinflammation, characterized by activated microglia and cytokine release, is implicated in Parkinson's disease (PD) and atypical parkinsonism (APD).
• Limited research exists on the specific differences in neuroinflammatory responses between PD and APD.
• This study focuses on comparing cerebrospinal fluid (CSF) cytokine profiles in PD, multiple system atrophy (MSA), and progressive supranuclear palsy (PSP).

Purpose of the Study:

• To investigate and compare CSF cytokine profiles in patients with PD, MSA, and PSP.
• To identify potential differences in neuroinflammation between PD and APD.
• To explore the diagnostic utility of specific cytokines and C-reactive protein (CRP) in differentiating these conditions.

Main Methods:

• Analyzed CSF samples from patients with PD (n=46), MSA (n=35), PSP (n=39), and controls (n=31).
• Measured C-reactive protein (CRP) and eight cytokines (IFN-γ, IL-10, IL-18, IL-1β, IL-4, IL-6, TGF-β1, TNF-α) using electrochemiluminescence.
• Assessed CSF total tau protein levels to correlate with neurodegeneration.

Main Results:

• Elevated levels of CRP and pro-inflammatory cytokines (TNF-α, IL-1β, IL-6) were observed in MSA and PSP patients compared to PD patients.
• No significant differences in these analytes were found between MSA and PSP patients.
• A combination of CRP, TNF-α, IL-1β, and IFN-γ showed diagnostic potential (AUC 0.77) for distinguishing PD from MSA.

Conclusions:

• Patients with MSA and PSP exhibit significantly higher levels of microglia-derived cytokines and CRP compared to PD patients.
• These findings suggest distinct neuroinflammatory profiles in different parkinsonian syndromes.
• Specific cytokine patterns may aid in differentiating PD from APD, particularly MSA.